ATE278018T1 - Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion - Google Patents
Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektionInfo
- Publication number
- ATE278018T1 ATE278018T1 AT93401538T AT93401538T ATE278018T1 AT E278018 T1 ATE278018 T1 AT E278018T1 AT 93401538 T AT93401538 T AT 93401538T AT 93401538 T AT93401538 T AT 93401538T AT E278018 T1 ATE278018 T1 AT E278018T1
- Authority
- AT
- Austria
- Prior art keywords
- sequences
- nucleotide
- fiv
- peptides
- antibodies
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000002773 nucleotide Substances 0.000 title abstract 3
- 206010061598 Immunodeficiency Diseases 0.000 title abstract 2
- 208000029462 Immunodeficiency disease Diseases 0.000 title abstract 2
- 230000007813 immunodeficiency Effects 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 241000713800 Feline immunodeficiency virus Species 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 241000282326 Felis catus Species 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 241000282324 Felis Species 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9207257A FR2692279B1 (fr) | 1992-06-16 | 1992-06-16 | Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline. |
| FR9207258A FR2692269B1 (fr) | 1992-06-16 | 1992-06-16 | Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline. |
| FR9214026A FR2692270A1 (fr) | 1992-06-16 | 1992-11-23 | Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE278018T1 true ATE278018T1 (de) | 2004-10-15 |
Family
ID=27252623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93401538T ATE278018T1 (de) | 1992-06-16 | 1993-06-16 | Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0577458B1 (de) |
| AT (1) | ATE278018T1 (de) |
| DE (1) | DE69333636T2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0670901A1 (de) * | 1993-03-11 | 1995-09-13 | Akzo Nobel N.V. | Polypeptidfragment das gegen immunoschwäche virus der katze neutralizieriende antikörper induziert |
| FR2721031B1 (fr) * | 1994-06-09 | 1996-07-26 | Centre Nat Rech Scient | Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic. |
| FR2732346B1 (fr) * | 1995-03-27 | 1997-05-30 | Centre Nat Rech Scient | Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications |
| US5820869A (en) * | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| FR2769916B1 (fr) | 1997-10-17 | 2000-12-01 | Centre Nat Rech Scient | Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales |
| FR2828687B1 (fr) * | 2001-08-17 | 2003-12-12 | Hippocampe | Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat |
| FR2828686B1 (fr) * | 2001-08-17 | 2003-12-12 | Hippocampe | Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat |
| FR2833598A1 (fr) * | 2001-12-17 | 2003-06-20 | Hippocampe | Oligopeptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat |
| US7776546B2 (en) | 2003-09-11 | 2010-08-17 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
| CA2556141A1 (en) * | 2004-02-19 | 2005-09-01 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
| US7335360B2 (en) * | 2004-06-30 | 2008-02-26 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2669338A1 (fr) * | 1990-11-21 | 1992-05-22 | Centre Nat Rech Scient | Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline. |
-
1993
- 1993-06-16 DE DE69333636T patent/DE69333636T2/de not_active Expired - Lifetime
- 1993-06-16 AT AT93401538T patent/ATE278018T1/de not_active IP Right Cessation
- 1993-06-16 EP EP93401538A patent/EP0577458B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69333636D1 (de) | 2004-11-04 |
| EP0577458B1 (de) | 2004-09-29 |
| DE69333636T2 (de) | 2005-10-06 |
| EP0577458A1 (de) | 1994-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE278018T1 (de) | Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion | |
| ITFI920052A1 (it) | Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico. | |
| DE69739981D1 (de) | Streptococcus pneumoniae-Antigene und Impfstoffe | |
| EA200100565A1 (ru) | Новые стрептококковые антигены | |
| ATE252640T1 (de) | Verbindungen zur immunotherapie und diagnose von tuberkulose | |
| ATE453403T1 (de) | Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert | |
| EP1542732A4 (de) | Fusionsproteine aus mycobakterium tuberculosis | |
| PT1219711E (pt) | Vacina de lawsonia intracellularis | |
| Simpson et al. | Identification of surface antigens of schistosomula of Schistosoma mansoni recognized by antibodies from mice immunized by chronic infection and by exposure to highly irradiated cercariae | |
| PT652287E (pt) | Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina | |
| HU9401511D0 (en) | Vaccine against streptococcus suls infection | |
| DE69637640D1 (de) | N und anwendungen | |
| DE69830325D1 (de) | Peptide des env-gens vom katze immunschwäche-virus und deren verwendung | |
| DK0474645T3 (da) | Proteinkompleks | |
| CA2190359A1 (en) | Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection | |
| CA2210294A1 (en) | Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens | |
| DK1094069T4 (da) | DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf | |
| DE60035485D1 (de) | IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407 | |
| Ito et al. | Recent advances in basic and applied science for the control of tacniasis/cysticercosis in Asia | |
| WO1993020103A3 (en) | Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification | |
| AR027443A1 (es) | MUTANTES DE EHV gM-NEGATIVOS | |
| TR199801776T2 (xx) | Tripanosomatid t�rlerine ba����kl�k | |
| WO2002083069A3 (en) | Recombinant proteins of orientia tsutsugamushi | |
| CA2262500A1 (en) | Measles virus mutant antigen and gene coding for the same | |
| Dempster | Identification of host-protective antigens from oncospheres of Echinococcus granulosus. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |